Vijay Sagar Madamsetty (Vijay S Madamsetty)

Loop profile ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Venues

ACS biomaterials science & engineering

Cancers

Leukemia & lymphoma

Oncogene

Mayo Clinic Research Florida

Indian Institute of Chemical Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mayo Clinic Research Florida Nov 11 2016

United States

Post doc :: Biochemistry and Molecular Biology

Education History

Indian Institute of Chemical Technology Oct 11 2010 - Jan 31 2018

India

PHD :: CHEMICAL BIOLOGY

Publications

Emmanuel M Gabriel, Deborah Bahr, Hari Krishnareddy Rachamala, Vijay Sagar Madamsetty, Barath Shreeder, Sanjay Bagaria, Amber L Escobedo, Joel M Reid, Debabrata Mukhopadhyay
Liposomal Phenylephrine Nanoparticles Enhance the Antitumor Activity of Intratumoral Chemotherapy in a Preclinical Model of Melanoma. ACS biomaterials science & engineering (2024)
Emmanuel M Gabriel, Deborah Bahr, Hari Krishnareddy Rachamala, Vijay Sagar Madamsetty, Barath Shreeder, Sanjay Bagaria, Amber L Escobedo, Joel M Reid, Debabrata Mukhopadhyay
Liposomal Phenylephrine Nanoparticles Enhance the Antitumor Activity of Intratumoral Chemotherapy in a Preclinical Model of Melanoma. ACS biomaterials science & engineering 10 (5) (2024)
Emmanuel M Gabriel, Deborah Bahr, Hari Krishnareddy Rachamala, Vijay Sagar Madamsetty, Barath Shreeder, Sanjay Bagaria, Amber L Escobedo, Joel M Reid, Debabrata Mukhopadhyay
Liposomal Phenylephrine Nanoparticles Enhance the Antitumor Activity of Intratumoral Chemotherapy in a Preclinical Model of Melanoma. ACS biomaterials science & engineering 10 (5) (2024)
Emmanuel M Gabriel, Deborah Bahr, Hari Krishnareddy Rachamala, Vijay Sagar Madamsetty, Barath Shreeder, Sanjay Bagaria, Amber L Escobedo, Joel M Reid, Debabrata Mukhopadhyay
Liposomal Phenylephrine Nanoparticles Enhance the Antitumor Activity of Intratumoral Chemotherapy in a Preclinical Model of Melanoma. ACS biomaterials science & engineering 10 (5) (2024)
Emmanuel M Gabriel, Deborah Bahr, Hari Krishnareddy Rachamala, Vijay Sagar Madamsetty, Barath Shreeder, Sanjay Bagaria, Amber L Escobedo, Joel M Reid, Debabrata Mukhopadhyay
Liposomal Phenylephrine Nanoparticles Enhance the Antitumor Activity of Intratumoral Chemotherapy in a Preclinical Model of Melanoma. ACS biomaterials science & engineering 10 (5) (2024)
Vijay Sagar Madamsetty, Reza Mohammadinejad, Ilona Uzieliene, Noushin Nabavi, Ali Dehshahri, Jomarien García-Couce, Shima Tavakol, Saeid Moghassemi, Arezoo Dadashzadeh, Pooyan Makvandi, Abbas Pardakhty, Abbas Aghaei Afshar, Ali Seyfoddin
Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems. ACS biomaterials science & engineering 8 (5) (2022)
Santosh Renuse, Vijay Sagar Madamsetty, Dong-Gi Mun, Anil K Madugundu, Smrita Singh, Savita Udainiya, Kiran K Mangalaparthi, Min-Sik Kim, Ren Liu, S Ram Kumar, Valery Krasnoperov, Mark Truty, Rondell P Graham, Parkash S Gill, Debabrata Mukhopadhyay, Akhilesh Pandey
Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer. Cancers 13 (14) (2021)
Ramcharan Singh Angom, Jian Zhu, Alexander Tsang-Hsien Wu, Maryam Rachmawati Sumitra, Victoria Pham, Shamit Dutta, Enfeng Wang, Vijay Sagar Madamsetty, Gabriel D Perez-Cordero, Hsu-Shan Huang, Debabrata Mukhopadhyay, Ying Wang
LCC-09, a Novel Salicylanilide Derivative, Exerts Anti-Inflammatory Effect in Vascular Endothelial Cells. Journal of inflammation research 14 (2021)
Sneha Vivekanandhan, Vijay Sagar Madamsetty, Ramcharan Singh Angom, Shamit Kumar Dutta, Enfeng Wang, Thomas R Caulfield, Alexandre A Pletnev, Rosanna Upstill-Goddard, Yan W Asmann, David K Chang, Mark R Spaller, Debabrata Mukhopadhyay
Role of PLEXIND1/TGFβ Signaling Axis in Pancreatic Ductal Adenocarcinoma Progression Correlates with the Mutational Status of KRAS. Cancers 13 (16) (2021)
Hari Krishnareddy Rachamalla, Santanu Bhattacharya, Ajaz Ahmad, Kathyayani Sridharan, Vijay Sagar Madamsetty, Sujan Kumar Mondal, Enfeng Wang, Shamit K Dutta, Basit L Jan, Sudhakar Jinka, Madan Mohan Chandra Sekhar Jaggarapu, Venu Yakati, Debabrata Mukhopadhyay, Khalid M Alkharfy, Rajkumar Banerjee
Enriched pharmacokinetic behavior and antitumor efficacy of thymoquinone by liposomal delivery. Nanomedicine (London, England) 16 (8) (2021)
Vijay Sagar Madamsetty, Aneel Paulus, Sharoon Akhtar, Alak Manna, Harikrishna Reddy Rachamalla, RajKumar Banerjee, Debabrata Mukhopadhyay, Asher Chanan-Khan
Novel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display anti-tumor activity in a xenograft model of bortezomib-resistant Waldenstrom macroglobulinemia. Leukemia & lymphoma 61 (10) (2020)
Ramcharan Singh Angom, Sujan Kumar Mondal, Fei Wang, Vijay Sagar Madamsetty, Enfeng Wang, Shamit K Dutta, Yash Gulani, Rachel Sarabia-Estrada, Jann N Sarkaria, Alfredo Quinones-Hinojosa, Debabrata Mukhopadhyay
Ablation of neuropilin-1 improves the therapeutic response in conventional drug-resistant glioblastoma multiforme. Oncogene 39 (48) (2020)
Ali Dehshahri, Anuj Kumar, Vijay Sagar Madamsetty, Ilona Uzieliene, Shima Tavakol, Fereshteh Azedi, Hojjat Samareh Fekri, Ali Zarrabi, Reza Mohammadinejad, Vijay Kumar Thakur
New Horizons in Hydrogels for Methotrexate Delivery. Gels (Basel, Switzerland) 7 (1) (2020)
Vijay Sagar Madamsetty, Krishnendu Pal, Shamit Kumar Dutta, Enfeng Wang, James R Thompson, Raj Kumar Banerjee, Thomas R Caulfield, Kabir Mody, Yun Yen, Debabrata Mukhopadhyay, Hsu-Shan Huang
Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity and Inhibition of Metastatic Pancreatic Ductal Adenocarcinoma. Bioconjugate chemistry 30 (10) (2019)
Vijay Sagar Madamsetty, Manash K Paul, Anubhab Mukherjee, Sudip Mukherjee
Functionalization of Nanomaterials and Their Application in Melanoma Cancer Theranostics. ACS biomaterials science & engineering 6 (1) (2019)
Krishnendu Pal, Vijay Sagar Madamsetty, Shamit Kumar Dutta, Enfeng Wang, Ramcharan Singh Angom, Debabrata Mukhopadhyay
Synchronous inhibition of mTOR and VEGF/NRP1 axis impedes tumor growth and metastasis in renal cancer. NPJ precision oncology 3 (2019)

Vijay Sagar Madamsetty.css-eqlu8i{font-size:small;padding-left:4px;} (Vijay S Madamsetty)

Publication Activity (10 Years)

Top Topics

Top Venues

Vijay Sagar Madamsetty (Vijay S Madamsetty)